Posts by ericg
Boston business leaders, Rwandan organization create new kind of entrepreneurship education
In Rwanda, a group impacted by the genocide in 1994 and poverty formed Rungano-Ndota to support some of the region’s most vulnerable youth, empowering them as people and entrepreneurs. Read More
Read More15-acre Newton site on market for $24M after deal falls through
A nearly 15-acre Newton property is back on the market after the demise of a tentative deal that involved the city and real estate developers NOW Communities and Civico. Read More
Read MoreA ‘behind the scenes’ woman rises to the top at Takeda
Julie Kim didn’t start her career as a natural leader. Then a manager told her that if she aspired to leadership, she needed to step out of her comfort zone — speak up at meetings, make herself known. Read More
Read MoreBoston VC firm OpenView winds down, dissolves $570M seventh fund
Earlier this year, the VC firm told the Business Journal it expected to make just under 20 investments out of its seventh fund. Read More
Read MoreLongmeadow Shops sold for $30.4M
The 62-year-old commercial center of the affluent bedroom community in Western Massachusetts was sold last week to a national property owner with headquarters in Florida. Read More
Read MoreMass General Brigham appoints first chief integration officer
Dr. O’Neil A. Britton will be Mass General Brigham’s first chief integration officer, as the state’s largest health system continues to combine services and staff across its many facilities. Read More
Read MoreGary Glick raises another $101M for immuno-oncology startup Odyssey Therapeutics
It’s the third nine-figure round the Boston-based startup has raised in as many years. Read More
Read MoreBoston PE firm raises $115M for 2nd fund, documents show
Launched in 2019 by Nik Shah and Daniel Gedney, Cohere Capital closed its first $200 million fund in the spring of 2020. Read More
Read MoreBoston-based Leerink Partners opens Miami office
Leerink Partners, a Boston-based healthcare investment firm, is expanding to Miami, marking the company’s sixth location in the U.S. Read More
Read MoreFlagship spinout Axcella collapses, leaving future of its long Covid drug uncertain
A Flagship Pioneering-backed biotech behind one of the only new drugs in development for long Covid is closing its doors. Read More
Read More